PGP and neoplasm: The suppression of TRPC5 activity as well as of P-gp expression reduced drug resistance and tumor growth both in vitro and in vivo suggesting that inhibiting either P-gp or TRPC5 could be an attractive strategy to overcome drug resistance (98).